Beta-alanine supplementation (DrugBank: Alanine, beta-Alanine)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 13 | 多発性硬化症／視神経脊髄炎 | 2 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03803800 (ClinicalTrials.gov) | January 9, 2019 | 9/1/2019 | Periodized Rehabilitation and Beta-alanine Supplementation in Multiple Sclerosis | Periodized Rehabilitation and Beta-alanine Supplementation in Multiple Sclerosis | Multiple Sclerosis | Other: Classic, progressive endurance training;Other: Periodized exercise training;Dietary Supplement: beta-alanine | Hasselt University | NULL | Completed | 18 Years | 75 Years | All | 31 | N/A | Belgium |
| 2 | NCT03418376 (ClinicalTrials.gov) | February 1, 2017 | 9/1/2018 | Carnosine Loading and Periodized Training in MS and HC | The Impact of Carnosine Loading and Rehabilitation Therapy on Exercise Capacity in Multiple Sclerosis. | Multiple Sclerosis;Exercise Therapy;Dietary Supplement | Dietary Supplement: Beta-alanine supplementation;Other: Exercise intervention | Hasselt University | NULL | Completed | 18 Years | 75 Years | All | 45 | N/A | Belgium |